AREC.L
Arecor Therapeutics PLC
Price:  
76.50 
GBP
Volume:  
371.00
United Kingdom | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AREC.L WACC - Weighted Average Cost of Capital

The WACC of Arecor Therapeutics PLC (AREC.L) is 12.7%.

The Cost of Equity of Arecor Therapeutics PLC (AREC.L) is 12.75%.
The Cost of Debt of Arecor Therapeutics PLC (AREC.L) is 7.25%.

Range Selected
Cost of equity 11.20% - 14.30% 12.75%
Tax rate 11.80% - 14.80% 13.30%
Cost of debt 7.00% - 7.50% 7.25%
WACC 11.2% - 14.2% 12.7%
WACC

AREC.L WACC calculation

Category Low High
Long-term bond rate 4.0% 4.5%
Equity market risk premium 6.0% 7.0%
Adjusted beta 1.21 1.33
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.20% 14.30%
Tax rate 11.80% 14.80%
Debt/Equity ratio 0.01 0.01
Cost of debt 7.00% 7.50%
After-tax WACC 11.2% 14.2%
Selected WACC 12.7%